Here in Vermont, the debate over H.237 has exposed a much bigger national conversation about access to mental health care, provider shortages, patient safety, and how the system adapts to growing demand.


The legislation, now signed into law as Act 84, allows certain doctoral-level psychologists in Vermont to prescribe psychiatric medications after completing specialized postdoctoral training, supervised clinical work, and entering into collaborative agreements with medical professionals.

Supporters say the bill is a response to reality.


Vermont, like much of the country, faces a severe shortage of psychiatrists and mental health providers, especially in rural communities. Patients often wait months for medication management appointments, and many areas simply do not have enough psychiatric prescribers. Advocates argue that highly trained psychologists already spend far more time with patients in therapy than many medication providers do, making them uniquely positioned to recognize symptoms, monitor progress, and provide integrated care.


Opponents, including some psychiatrists and medical organizations, argue that psychologists do not receive the same depth of medical training as physicians. Their concern centers on the risks of prescribing medications that can interact with physical health conditions, other prescriptions, heart issues, neurological disorders, or substance use complications. Critics warn that expanding prescribing authority could create patient safety concerns if oversight and training standards are not rigorous enough.


The law itself attempts to address those concerns through restrictions and safeguards. Under H.237, prescribing psychologists must complete advanced psychopharmacology education and supervised clinical training. Their authority is limited to mental health conditions, and there are restrictions involving children, elderly patients, pregnancy, injectable drugs, and controlled substances. Collaborative agreements with licensed prescribers are also required.


Nationally, Vermont joins only a small group of states that allow psychologists to prescribe medications. States including New Mexico, Louisiana, Illinois, Iowa, and Idaho have adopted versions of similar laws over the past two decades. Supporters point to those states as evidence that the model can work safely when properly regulated. Opponents argue the long-term data remains limited and that expanding psychiatry residency programs would be a better solution.

The bigger question may be where mental health treatment is heading overall. The field is moving toward more integrated and personalized care, combining therapy, medication, neuroscience, digital monitoring, telehealth, trauma-informed treatment, and potentially psychedelic-assisted therapies now being studied nationwide. Vermont has increasingly become part of those conversations, particularly around alternative treatment models, rural access, and behavioral health reform.

At the same time, there is growing frustration with a system many people feel is already overwhelmed. Patients struggling with anxiety, depression, PTSD, addiction, or severe mental illness often face long waits, provider shortages, insurance barriers, and fragmented care. H.237 reflects one attempt to expand the workforce and rethink who can safely participate in treatment delivery.


The reality is that both sides of the debate are arguing from legitimate concerns. One side sees urgency in expanding access during a mental health crisis. The other sees caution as essential when powerful medications are involved.


And Vermont now becomes one of the newest testing grounds for how that balance will work in practice. Please enjoy this episode, keep the comments coming. Rick Barnett is paying attention to them and cares about your prespective.